Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
| Autor: | Takeuchi, K. *, Togashi, Y., Kamihara, Y., Fukuyama, T., Yoshioka, H., Inoue, A., Katsuki, H., Kiura, K., Nakagawa, K., Seto, T., Maemondo, M., Hida, T., Harada, M., Ohe, Y., Nogami, N., Yamamoto, N., Nishio, M., Tamura, T. |
|---|---|
| Zdroj: | In Annals of Oncology January 2016 27(1):185-192 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|